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Abstract 
Cartilage is a vital organ to maintain joint function. Upon arthritis, proteolytic 
enzymes initiate degradation of cartilage extracellular matrix (ECM) resulting in 
eventual loss of joint function. However, there are only limited ways of non-
invasively monitoring early chemical changes in cartilage matrix. Here we report that 
the autofluorescence decay profiles of cartilage tissue are significantly affected by 
proteolytic degradation of cartilage ECM and can be characterised by measurements 
of the autofluorescence lifetime (AFL). A compact multidimensional fluorometer 
coupled to a fibre-optic probe was developed for single point measurements of AFL 
and applied to cartilage that was treated with different proteinases. Upon treating 
cartilage with bacterial collagenase, trypsin or matrix metalloproteinase 1, a 
significant dose and time dependent decrease of AFL was observed. Our data suggest 
that AFL of cartilage tissue is a potential non-invasive readout to monitor cartilage 
matrix integrity that may contribute to future diagnosis of cartilage defects as well as 
monitoring the efficacy of anti-joint therapeutic agents.  
 
Keywords 
Cartilage, collagen, aggrecan, auto fluorescent lifetime 
 
Abbreviations 
AFL: autofluorescence lifetime 
FL: fluorescence lifetime 
MMP: matrix metalloproteinase 
OA: osteoarthritis  
RA: rheumatoid arthritis 
 3 
INTRODUCTION 
 Cartilage is a unique avascular tissue composed of a dispersed population of 
chondrocytes and rich extracellular matrix (ECM). Cartilage ECM is predominantly 
composed of type II collagen and aggrecan proteoglycans (about 45 % each) with 
other minor components including small leucine rich proteoglycans and type IX and 
XI collagens (Heinegård et al., 2001; Sledge et al., 2001). In arthritic cartilage, these 
components are degraded by proteolytic enzymes, and the main proteinases 
responsible for cartilage matrix degradation are matrix metalloporeinases (MMPs) 
and disintegrin-metalloporteinases with thrombospondin motif (ADAMTSs)(Murphy 
and Nagase, 2008). Collagen is degraded by collagenases belonging to the MMPs 
family and aggrecan by MMPs and ADAMTSs. It is proposed that aggrecan is 
degraded in the early stage of arthritis and is followed by collagen degradation. This 
earlier aggrecan depletion is thought to be due to the action of aggrecanases belonging 
to ADAMTSs family including ADAMTS-4 and -5 (Murphy and Nagase, 2008; 
Stanton et al., 2011). Indeed, cartilage matrix of ADAMTS-5 null mice was shown to 
be largely protected from challenges against antigen-induced arthritis (Stanton et al., 
2005) and a mouse osteoarthritis (OA) model has been induced by surgical de-
stabilisation of knee joints (Glasson et al., 2005). In human OA cartilage, cleaved 
collagen products have been detected in cartilage tissue from the articular surface to 
deeper areas where extensive degeneration is apparent (Hollander et al., 1995; Wu et 
al., 2002).  Together, these proteolytic modifications of cartilage ECM by multiple 
proteinases result in loss of joint function, which is largely irreversible. Therefore 
there is a need to detect early biochemical changes of cartilage matrix, but the 
currently used methods of x-ray and magnetic resonance imaging detect only 
structural alteration of joint lesions.  
 4 
Measurement of autofluorescence lifetime (AFL) has been shown to detect 
qualitative chemical changes of tissue (Elson et al., 2004; Manning et al., 2008b; 
Talbot et al., 2010). Fluorescence is the spontaneous emission of a photon as an 
electron relaxes to its ground state following excitation to a higher energy level. The 
average time during which an excited electron remains in the excited state is defined 
as the fluorescence lifetime (FL) and this intrinsic parameter can distinguish different 
molecular species.  FL measurements are independent of fluorophore concentration 
and the efficiency of excitation and detection of the emission, making them more 
robust than fluorescence intensity measurements.  For some fluorophores, the FL can 
be modified by changes in the local chemical or physical environment and so can be 
utilised to report on variations in, e.g. viscosity, pH, refractive index, solvent polarity 
and ionic concentrations (Lakowicz, 2006). One of the major fluorophores present in 
the cartilage matrix is collagen (Georgakoudi et al., 2002; Menter, 2006). Because 
interstitial collagen polypeptides contain only 7 tryptophans, 10 tyrosines and 25 
phenylalanines out of about 1,000 amino acids, the major source of fluorescent signal 
in collagen matrix is its intermolecular cross-links (Wagnieres et al., 1998). In intact 
cartilage, collagens exist as fibriler forms that are surrounded by aggrecan and other 
minor ECM components, including small leucine-rich proteoglycans, and the collagen 
AFL is thought to be sensitive to alterations in these local components. In this study 
we tested this hypothesis by studying cartilage tissue treated with various proteinases 
as a starting point and have demonstrated that AFL can detect the degradation of 
ECM.  
 
RESULTS 
Autofluorescence lifetime of normal cartilage 
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A major cartilage component, type II collagen, is considered to be the main 
source of autofluorescence in the tissue.  Although it contains limited numbers of 
aromatic amino acids, including 7 tryptophans, 10 tyrosines and 25 phenylalanines, 
the fluorescence of these molecules is excited only in the far UV (Lakowicz, 2006). 
For excitation in the more accessible near UV spectral region at 355 nm, we expect to 
observe fluorescence from the cross-links between collagen molecules (Wagnieres et 
al., 1998).  As shown in Figure 1, our measured excitation-emission matrix of bovine 
type II collagen indicates that excitation at 355 nm produces peak autofluorescence 
emission 390-430 nm, which is readily detected.  
To investigate potential autofluorescence lifetime contrast, we analyzed 
porcine articular cartilage using our multidimensional fluorometer and recorded the 
fluorescence emission resolved with respect to time and wavelength. Figure 2A shows 
the spectro-temporal characteristics of the cartilage autofluorescence excited with 
picosecond pulses at 355 nm and figure 2B shows the time-integrated emission 
spectrum. The temporal decay profile of the cartilage autofluorescence was fitted to 
both a single exponential and a double exponential decay profile and the double 
exponential decay model,   1 21 2
t t
I t e e
  
 
  was found to provide a superior fit 
with smaller weighted residuals and a χ2 close to unity.  The values obtained for the 
corresponding fit parameters are given in Table 1. Our data indicates an 
autofluorescence decay profile of this cartilage tissue comprising a 12.82 ns AFL 
component (providing 76.4% of the total fluorescence signal) and a 1.74 ns AFL 
component (23.6%), resulting in a mean AFL of 10.2 ns.   The mean lifetime was not 
observed to vary with emission wavelength.  Figure 2C shows a typical 
autofluorescence decay profile recorded at 415 nm, together with the temporal profile 
of the instrument response function (IRF) and the fit to the double exponential decay 
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model. Figure 2D shows the results of repeated measurements of porcine articular 
cartilage (n=21) provided a mean AFL of 9.9 ± 0.2 ns (mean ± SEM) (Figure 2D). 
The AFL was found to vary between different areas of cartilage and different cartilage 
pieces, potentially reflecting differences of chemical environment of collagen fibrils 
in each area.    
Fluorescence changes associated with cartilage degradation 
To examine effects of proteolytic degradation of cartilage on AFL, frozen and 
thawed porcine articular cartilage was treated with bacterial collagenase.  A high 
concentration of collagenase (1 mg/ml) dissolved cartilage tissues almost completely 
within 18 h at 37 °C (data not shown), indicating that this enzyme can degrade both of 
the major components of cartilage, i.e. collagen and aggrecan.  Thus the action of 
bacterial collagenase on cartilage can simulate the condition of arthritic cartilage 
being degraded by multiple proteinases.  We treated porcine cartilage with different 
concentrations of the collagenase ranging from 10 μg/ml to 100 μg/ml at 37 °C for 
16 h. Treating cartilage with 100 μg/ml for 16 h resulted in 50% of collagen release 
from cartilage pieces (data not shown). The autofluorescence of each cartilage sample 
was measured five times using an optical fiber probe attached to the multidimensional 
fluorometer with picosecond pulsed excitation at 355 nm and emission measured at 
415 nm.  Figure 3A shows the autofluorescence decay traces and Figure 3B shows the 
variation of calculated mean AFL for a range of collagenase concentrations. The data 
indicate that enzyme treatment decreases the mean AFL of cartilage and there is a 
clear inverse correlation between mean AFL and concentration of collagenase treated 
as demonstrated by a good fit to a linear equation (r
2
 = 0.90). The behavior of the 
mean AFL lifetime can be traced back to both a decrease in the lifetime of the long 
component of the double exponential fit (data not shown) and an increased relative 
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contribution from the shorter component (Figure 3C). Interestingly, the collagenase 
treatment did not affect the autofluorescence emission spectrum of cartilage (Figure 
3D), suggesting that the relative concentrations of constituent fluorophores was not 
affected by the enzyme treatment.  
The above experiments were carried out by measuring a number of cartilage 
pieces treated with the enzyme.  To confirm that the shift of AFL truly reflects 
changes caused by the enzyme treatment and was not due to heterogeneity of cartilage 
tissues, we monitored a three cartilage samples over a period of treatment with the 
enzyme and a further three samples that were untreated. The same area of the same 
cartilage piece were analyzed at each time point of incubation. As shown in Figure 4, 
the AFL of control cartilage was almost unchanged over the incubation period of 6 h 
with only slight decrease from 8.4 ± 0.03 ns (time 0) to 8.2 ± 0.06 ns (6 h). On the 
other hand, treatment with bacterial collagenase significantly decreased the AFL in 
every time point over the 6 h period. The data suggest that decrease of AFL by the 
enzyme treatment is indeed a result of action of enzyme to the cartilage matrix.  
Effect of aggrecan degradation and interstitial collagenase, MMP-1 
 Ｗe next investigated the effect of aggrecan removal and collagen removal in 
cartilage in selective manner to . As shown in Figure 5A, trypsin at 100 μg/ml 
effectively degrades and removes aggrecan from the cartilage but does not degrade 
type II collagen.  Treating cartilage with MMP-1 at 4 μg/ml also resulted in aggrecan 
removal up to 40%, with modest collagen degradation of 10%, suggesting that MMP-
1 acts on aggrecan first and then collagen.  Treating live cartilage with retinoic acid 
induces expression of aggrecanases and removes aggrecan but not collagen from the 
cartilage effectively.  As shown in Figure 5B, after treating cartilage for 3 days with 
retinoic acid, aggrecan in the cartilage was almost completely removed, but there are 
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no collagen degradation observed.   
We examined the effect of aggrecan removal by trypsin on AFL in porcine 
cartilage.  As shown in Figure 5C, trypsin treatment reduced the AFL in a statistically 
significant manner. We next examined the effect of MMP-1 treatment on porcine 
cartilage. As shown in Figure 5D, treating cartilage with MMP-1 caused significant 
decrease of the mean AFL in a dose dependent manner. At a concentration of 
50 μg/ml, the significant decrease of AFL corresponded to about 50 % of collagen 
released to culture medium (data not shown). Finally, we examined effect of aggrecan 
removal by inducing expression of endogenous aggrecanses with retinoic acid (RA) 
treatment (Flannery et al., 1999). As shown in Figure 5E, cartilage treated with RA 
exhibited significantly lower AFL.   
 
Fluorescence lifetime imaging of cartilage tissue treated with collagenase 
To confirm the data obtained above using the single-point fibre-optic probe 
AFL measurements, we also utilized wide-field fluorescence lifetime microscopy.  
For this, a cartilage piece was split into halves and one piece was incubated in the 
buffer while the other piece was treated either with bacterial collagenase or human 
MMP-1 for 24 and 48 hours, respectively. For buffer control samples, one piece was 
incubated in the buffer and the other froze down immediately without incubation. 
After incubation, the two halves of cartilages were placed back together and the 
interface imaged with the fluorescence lifetime microscope. As shown in Figure 6A, 
incubating cartilage pieces in the buffer for 48 hours did not result in any change in 
their AFL.  On the other hand, incubating with bacterial collagenase or MMP-1 
caused a reduction of AFL compared to the cartilage pieces incubated in the buffer 
alone.  Due to the relatively low fluorescence signal recorded in each pixel of the 
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autofluorescence image, the decay data was fitted to a single exponential decay model, 
since there were insufficient photons to accurately fit a double exponential decay 
model.  While this is less rigorous, yielding noticeable differences in AFL values (~6 
ns) compared to the double exponential fits to the data obtained with the single-point 
fluorometer probe (typically ~8-10 ns), it does permit the lifetime contrast between 
different regions of the sample to be visualised, clearly showing that the degraded 
area of cartilage showed significantly lower lifetimes relative to intact area of 
cartilage.  These results confirm the trends observed using the multidimensional 
fluorometer, indicating that cartilage matrix degradation has led to a detectable 
decrease in AFL and suggesting that AFL may provide useful to identify degraded 
areas of cartilage.   
 
DISCUSSION 
The function of cartilage depends on its extracellular matrix (ECM).  Collagen 
provides tissue architecture and tensile strength to the tissue, and aggrecan provides 
its compression resistant property by maintaining water molecules in the tissue. Thus, 
the degradation of these ECM components severely compromises the joint function.  
In this manuscript, we demonstrate that AFL can be a potential label-free means to 
detect changes in cartilage matrix in a non-invasive manner.  The advantage of AFL 
measurement is that the detection of autofluorescence of endogenous ECM 
components does not involve administration of exogenous fluorescent labels and 
therefore may provide a means to probe live tissues.  
Upon proteolytic actions in the cartilage, the mean AFL decreased over time 
and according to the level of degradation.  Bacterial collagenase, which can dissolve 
cartilage tissue effectively, significantly decreased the mean AFL. In this treatment, it 
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is likely that the bacterial collagenase degrades both collagen and aggrecan as this 
preparation of bacterial collagenase (Type 2) is known to have a contamination of a 
trypsin-like enzyme. Indeed treating cartilage with 100 μg/ml for 24 h released 80% 
of collagen as well as 80 % of aggrecan from the cartilage tissue (data not shown). To 
more specifically examine the effect of loss of aggrecan, cartilage tissue was treated 
with trypsin. Since aggrecan provides a viscous environment between the collagen 
fibrils, its removal was expected to affect the cartilage AFL.  In our experiments the 
complete aggrecan removal by trypsin had a statistically significant and reproducible 
(figure 5C) effect on AFL. A similar decrease was also detected when live cartilage 
was treated with 10 μM retinoic acids for three days to induce endogenous 
aggrecanases which removed aggrecan almost completely from the cartilage tissue. 
Treating cartilage with active form of mammalian collagenase, MMP-1, also 
decreased the AFL in a more significant manner as shown in figure 5D. During the 
course of the MMP-1 treatment, aggrecan was released in an unexpectedly efficient 
manner, and this was followed by collagen degradation. We found 50 μg/ml MMP-1 
treatment resulted in about 50% of collagen release and 60 % of aggrecan release 
from the cartilage. We therefore attribute the significant shift in the mean AFL 
observed for a relatively high concentration of MMP-1 to the both collagen 
degradation and aggrecan degradation. In cartilage, collagen exists as fibrils. The 
MMP-1 cleavage site in monomeric collagen locates at the three quarter from the N-
terminus (Visse and Nagase, 2003).  Within a fibril, the cleavage site of collagen is 
located at close to the telopeptides of other collagen molecules where inter-molecule 
crosslinking occurs (Perumal et al., 2008).  It is thus possible that cleavage of 
collagen by MMP-1 affects the local environment of crosslinks that are sources of 
autofluorescence in collagen molecules and hence affects the AFL. In osteoarthritic 
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cartilage, collagen degradation was found to occur progressively from the surface of 
the tissue and around the chondrocytes (Hollander et al., 1995). It is not clear which 
collagenolytic MMPs are playing a role in this collagenolysis, but it is expected that 
collagenolytic action on cartilage tissue by any of the collagenolytic MMPs including 
MMP-1, MMP-2, MMP-8, MMP-13 and MMP-14 would change the AFL since they 
all cleave the Gly-Leu or Gly-Gln of the same region in the collagen II molecule 
(Knäuper et al., 1996; Mitchell et al., 1996; Ohuchi et al., 1997; Patterson et al., 2001). 
Therefore AFL could provide a useful means to monitor cartilage matrix degradation.   
The multidimensional fluorometer could be considerably simplified, e.g. by 
dispensing with the spectral resolution, such that it could become portable and 
clinically deployable, for example by adapting the fibre optic probe for in vivo 
“needle biopsy”.  Furthermore, a FLIM instrument could be developed for 
arthroscopic application (Requejo-Isidro et al., 2004) and so provide a novel means to 
image the status of cartilage in a non-invasive manner.  It is therefore important to 
further validate AFL measurements of cartilage degradation and this will be the 
subject of future investigations.   
 
EXPERIMENTAL PROCEDURES 
Materials 
Bovine type-II collagen and trypsin was purchased from Sigma-Aldrich 
(Dorset, UK). Bacterial collagenase type 2 was purchased from Worthington 
Biochemical Corp (Lakewood, NJ, USA).  
Recombinant MMP-1 was expressed in E.coli, purified and activated as previously 
reported (Chung et al., 2000; Jozic et al., 2005). 
Single-point fibre-optic multidimensional fluorometer probe 
 12 
The AFL measurements were undertaken using a single-point 
multidimensional fluorometer implemented with a fibre-optic probe as described 
previously (Manning et al., 2008a). This instrument facilitates measurements of 
fluorescence resolved with respect to excitation and emission wavelength, 
fluorescence lifetime and polarisation. It was configured with a diode-pumped 
frequency-tripled Neodymium Vanadate laser (Vanguard 350-HM355, Spectra-
Physics, USA) as the excitation source, which provides 12 ps pulses at 80 MHz 
repetition rate centred on 355 nm wavelength.  The custom-built fibre-optic probe 
(FiberTech Optica, Canada) incorporated three excitation fibres and 16 collection 
fibres. The fluorescence detection was a motorised monochromator (CM110, CVI 
Inc., USA) and a cooled photomultiplier (PMC-100, Becker-Hickl GmbH, Germany) 
to provide single channel spectrally resolved detection with time-resolution 
implemented using time-correlated single photon counting (SPC 730, Becker-Hickl 
GmbH, Germany). The fitting of fluorescence lifetime data was undertaken using the 
software package TRFA (SSTC, Belarus).   
Cartilage explant 
 Porcine articular cartilage and bovine nasal cartilage were obtained from 
slaughterhouse and were prepared as previously described (Gendron et al., 2003; 
Miller et al., 2009). Cartilage pieces (approx. 5 mm x 5 mm x 2.5 mm) were frozen 
and thawed 3 times to kill chondrocytes and kept in -20°C until they are subjected to 
experiments. 
Analysis of glycosaminoglycan (GAG) and hydroxyproline release 
GAG released into the conditioned medium was measured in triplicate using a 
modification of the DMMB assay as described previously (Farndale et al., 1986; 
Gendron et al., 2003). Shark chondroitin sulfate (0-2.62 μg) was used as the standard. 
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The percentage of total GAG released into the medium was calculated as follows: % 
of total GAG released=(total GAG in the medium)/(total GAG in the medium+total 
GAG remaining in the cartilage). All data were analyzed by unpaired one-tail t tests 
with Welch’s correction using the software package GraphPad Prism (San Diego, CA, 
USA). Hydroxyproline release into the conditioned medium was measured according 
to Woessner (Woessner, 1961). The amount released was calculated according to the 
standard curve. All data were analyzed by unpaired one-tail t tests with Welch’s 
correction using the software package GraphPad Prism. 
Wide-field fluorescence lifetime imaging 
 Fluorescence lifetime imaging was implemented in a wide-field microscope as 
described previously (Dowling et al., 1998; Talbot et al., 2010).  Briefly, wide-field 
time-gated detection was implemented on a conventional wide-field inverted 
fluorescence microscope frame (Olympus IX81) configured for excitation at 365 nm 
using an 80MHz frequency-doubled Ti:Sapphire laser (MaiTai, Spectra Physics).  
Wide-field FLIM was implemented using a gated optical image intensifier (HRI, 
Kentech Instruments Ltd, Didcot, UK) read out by a cooled CCD camera (Orca-ER, 
Hamamatsu Photonics KK, Shizuoka-Ken, Japan).   
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FIGURE LEGENDS 
Figure 1. Excitation-emission matrix of bovine type II collagen 
Excitation-emission matrix of lyophilized type II collagen recorded using a 
commercial spectrofluorometer (Shimadzu). Pseudocolor scale represents relative 
fluorescence intensity in arbitrary units where the highest is red and lowest is dark 
blue.  Reported sources of autofluorescence in collagen are indicated with arrows 
(Lakowicz, 2006). 
 
Figure 2. Auto-fluorescence lifetime of cartilage tissue 
(A) Time-resolved emission spectrum and (B) time–integrated emission spectrum of 
fresh porcine articular cartilage excited at 355 nm by 12 ps pulses at 80 MHz 
repetition rate measured using multidimensional fluorometer via fibre optic probe. (C) 
Cartilage autofluorescence decay profile (blue curve) acquired at 355 nm/415 nm 
excitation/emission with instrument response function (IRF, black curve) and double 
exponential fit (red curve) with residuals to fit (green curve). (D) Dot plot of mean 
AFL measurements of frozen and thawed porcine articular cartilage (n=21). The AFL 
value is 9.9 ± 0.2 ns (mean ± SEM). 
 
Figure 3. Effect of collagnese on the AFL of porcine articular cartilage 
(A) Fluorescence decay profiles of porcine articular cartilage treated with different 
concentration of bacterial collagenase (0 to 100 μg/ml) at 37 °C for 16 h as indicated.  
(B) Mean AFL of porcine articular cartilage treated with different concentrations of 
bacterial collagenase. Error bars (SEM) shown are from five separate measurements 
each on five different cartilages of each dose. A linear fit to the data point is shown 
with AFL=39.25 – 0.04[C], where [C] is the concentration of collagenase (r2=0.90. 
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(C) Percentage of autofluorescence photons emitted from the shorter lifetime 
component, showing that the contribution of the shorter component increases in a 
dose dependent manner. The lifetime of the longer component decreased with 
concentration (data not shown).   
(D) Time-integrated and normalised fluorescence emission spectra excited at 355 nm 
of cartilage treated with 100 μg/ml collagenase for 16 h at 37 °C (red) or with the 
buffer control (blue). 
 
Figure 4. Time-dependent effect of bacterial collagenase-treatment on Cartilage 
AFL 
Cartilage samples were treated with (n=3) or without (n=3) bacterial collagenase (200 
μg/ml) at 37 °C over the period of 6 h. AFL of the same area of the same cartilage 
piece was measured at each time point, and plotted. *P<0.013; **P<0.007; 
***P<0.0004. 
 
Figure 5. Effect of trypsin or MMP-1 treatment on cartilage AFL 
(A) Freeze and thawed porcine articular cartilage treated with trypsin (2.5 μg/ml) or 
MMP-1 (4 μg/ml) or in the buffer alone at 37 °C for 72 h. Supernatants were collected 
and subjected to DMMB assay for aggrecan release and Hydroxy proline (Hy-Pro) 
assay for collagen release (n=12).  
(B) Live porcine articular cartilage was treated with or without 10 μM retinoic acid 
(RA) for three days.  Culture supernatants were collected and subjected to DMMB 
assay for aggrecan release and Hy-Pro assay for collagen release (n=10). 
(C) Mean AFL of porcine cartilage samples treated with or without trypsin (100 
μg/ml) at 37 °C for 24 h and measured using multidimensional fluorometer via fiber-
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optic probe (n= 9 for control and 8 for trypsin. ***p<0.0009). 
(D) Mean AFL of porcine cartilage treated with MMP-1 (50 μg/ml) at 37 °C for 96 h. 
Mean AFL are indicated with SEM. (n=5)  ***p<0.0009, ****p<0.0002, 
*****p<0.0001. 
(E) Mean AFL of porcine cartilage treated with RA. Mean AFL are indicated with 
SEM. 
 
Figure 6. FLIM cartilage degradation by collagenase 
(A) Autofluorescence lifetime images fitted to a single exponential decay model 
(AFLIM, upper row) and time-integrated intensity images (lower row) of 
autofluorescence of cartilage pieces. A cartilage piece was halved and one piece was 
soaked in the buffer containing with or without bacterial collagenase (50 μg/ml) for 
24 h or human active MMP-1 (50 µg/ml) for 48 h in humidified incubator at 37 °C.  
The other piece of cartilage was either frozen down immediately (Buffer control) or 
incubated with buffer without enzymes for the same length of time as the other piece. 
Two paired pieces of cartilages were then put together, and interface of cartilages 
were imaged using the wide-field FLIM microscope. AFLIM maps have been merged 
with the intensity data and shown.  (B) Bar charts showing mean lifetime differences 
between the control and treated cartilage for the different conditions.   
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